Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
PLoS Biol. 2020 Dec 7;18(12):e3000963. doi: 10.1371/journal.pbio.3000963. eCollection 2020 Dec.
Approximately 28% of the human population have been exposed to Mycobacterium tuberculosis (MTB), with the overwhelming majority of infected individuals not developing disease (latent TB infection (LTBI)). While it is known that uncontrolled HIV infection is a major risk factor for the development of TB, the effect of underlying LTBI on HIV disease progression is less well characterized, in part because longitudinal data are lacking. We sorted all participants of the Swiss HIV Cohort Study (SHCS) with at least 1 documented MTB test into one of the 3 groups: MTB uninfected, LTBI, or active TB. To detect differences in the HIV set point viral load (SPVL), linear regression was used; the frequency of the most common opportunistic infections (OIs) in the SHCS between MTB uninfected patients, patients with LTBI, and patients with active TB were compared using logistic regression and time-to-event analyses. In adjusted models, we corrected for baseline demographic characteristics, i.e., HIV transmission risk group and gender, geographic region, year of HIV diagnosis, and CD4 nadir. A total of 13,943 SHCS patients had at least 1 MTB test documented, of whom 840 (6.0%) had LTBI and 770 (5.5%) developed active TB. Compared to MTB uninfected patients, LTBI was associated with a 0.24 decreased log HIV SPVL in the adjusted model (p < 0.0001). Patients with LTBI had lower odds of having candida stomatitis (adjusted odds ratio (OR) = 0.68, p = 0.0035) and oral hairy leukoplakia (adjusted OR = 0.67, p = 0.033) when compared to MTB uninfected patients. The association of LTBI with a reduced HIV set point virus load and fewer unrelated infections in HIV/TB coinfected patients suggests a more complex interaction between LTBI and HIV than previously assumed.
约 28%的人口曾接触过结核分枝杆菌(MTB),绝大多数受感染者并未发病(潜伏性结核感染(LTBI))。虽然众所周知,未控制的 HIV 感染是发展为结核病的主要危险因素,但 LTBI 对 HIV 疾病进展的影响尚未得到很好的描述,部分原因是缺乏纵向数据。我们将瑞士艾滋病毒队列研究(SHCS)中所有至少有 1 次 MTB 检测记录的参与者分为 3 组之一:MTB 未感染、LTBI 或活动性 TB。为了检测 HIV 固定病毒载量(SPVL)的差异,我们使用线性回归;使用逻辑回归和时间事件分析比较 MTB 未感染患者、LTBI 患者和活动性 TB 患者之间 SHCS 中最常见机会性感染(OI)的频率。在调整模型中,我们校正了基线人口统计学特征,即 HIV 传播风险组和性别、地理位置、HIV 诊断年份和 CD4 最低点。共有 13943 名 SHCS 患者至少有 1 次 MTB 检测记录,其中 840 名(6.0%)患有 LTBI,770 名(5.5%)患有活动性 TB。与 MTB 未感染患者相比,LTBI 在调整模型中与 HIV SPVL 降低 0.24 对数相关(p<0.0001)。与 MTB 未感染患者相比,LTBI 患者发生口腔念珠菌病的几率较低(调整后的优势比(OR)=0.68,p=0.0035)和口腔毛状白斑(调整后的 OR=0.67,p=0.033)。LTBI 与 HIV/TB 合并感染患者 HIV 固定病毒载量降低和无关感染减少之间的关联表明 LTBI 与 HIV 之间的相互作用比之前假设的更为复杂。